But they do have this good news in their report:
November 30, 2022: In western Uganda, the Ebola outbreak that began in September has seen a decline in cases because of rapid medical response. Reported cases have declined but despite that decline, Uganda has closed schools nation-wide in an attempt to curb the spread of the Ebola virus. In November eight children died from Ebola in Uganda. The spread of Ebola to neighboring Congo seems to have been halted.....
Andrew Wefwafa had a series of videos about this
.....this was caused by the Sudan variation of the virus, and the problem is that the vaccine that helped stop the previous epidemics in central Africa were for a different strain.
Just recently, a new experimental vaccine for this Ebola strain has been sent there. LINK The doses are from the Sabin Vaccine Institute (SVI), according to Reuters. The SVI vaccine is a modified chimpanzee adenovirus (ChAd3) vector vaccine.
note: The adenovirus vector is what was used in the british AZ vaccine for covid, and for previous Ebola vaccines .
Health officials had earlier cleared plans to study three candidate Ebola Sudan vaccines. The others are from Merck and Oxford University.
In the middle of November, a WHO working group recommended that ring vaccine trials prioritize the Merck candidate first, owing to the safety and efficacy of the VSV-EBOV platform used for the Zaire Ebola vaccine, followed by the SVI vaccine, then the Oxford vaccine. A sharp decline in Uganda's Ebola cases presents an obstacle to ring vaccination trials. essentially the disease was stopped by isolation etc. so we will not be able to prove the vaccine works. /sarcasm.WHO Report.
The ring procedure is to isolate the cases, and vaccinate the ones in contact, then vaccinate the ones who were in contact with the contacts, etc.
.......
No comments:
Post a Comment